Comparison of in vitro activities of ceftazidime, piperacillin-tazobactam, and cefoperazone-sulbactam, and the implication on empirical therapy in patients with cancer.

Prabhash, K; Medhekar, A; Biswas, S; Kurkure, P; Nair, R; Kelkar, R

Prabhash, K; Medhekar, A; Biswas, S; Kurkure, P; Nair, R; Kelkar, R.

Indian J Cancer ; 2009 Oct-Dec; 46(4): 318-322

Article in En | IMSEAR | ID: sea-144268

Subject(s)

Anti-Bacterial Agents/pharmacology; Bacterial Infections/drug therapy; Bacterial Infections/etiology; Cefoperazone/pharmacology; Ceftazidime/pharmacology; Drug Resistance, Microbial; Empirical Research; Gram-Negative Bacteria/drug effects; Humans; Microbial Sensitivity Tests; Neoplasms/complications; Neoplasms/drug therapy; Penicillanic Acid/analogs & derivatives; Penicillanic Acid/pharmacology; Piperacillin/pharmacology; Retrospective Studies; Sulbactam/pharmacology

Key words

Antibiotics; sensitivity patterns; empirical treatment; oncology

Fulltext

Add to My VHL

XML

Search on Google

Full text: 1 Index: IMSEAR Main subject: Piperacillin / Bacterial Infections / Humans / Drug Resistance, Microbial / Microbial Sensitivity Tests / Sulbactam / Cefoperazone / Ceftazidime / Retrospective Studies / Penicillanic Acid Type of study: Guideline / Observational_studies Language: En Journal: Indian J Cancer Year: 2009 Type: Article

Fulltext

Add to My VHL

XML

Search on Google